Anna Furniss
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 12 | 2025 | 1449 | 0.730 |
Why?
| | Klinefelter Syndrome | 3 | 2025 | 68 | 0.570 |
Why?
| | Turner Syndrome | 3 | 2025 | 61 | 0.570 |
Why?
| | Neurodevelopmental Disorders | 4 | 2025 | 239 | 0.510 |
Why?
| | Parents | 7 | 2025 | 1394 | 0.480 |
Why?
| | Papillomavirus Vaccines | 4 | 2024 | 296 | 0.470 |
Why?
| | Mental Disorders | 4 | 2025 | 1148 | 0.430 |
Why?
| | Adrenal Hyperplasia, Congenital | 2 | 2025 | 39 | 0.380 |
Why?
| | Overweight | 5 | 2023 | 614 | 0.360 |
Why?
| | Reminder Systems | 3 | 2016 | 149 | 0.310 |
Why?
| | Transgender Persons | 2 | 2024 | 213 | 0.300 |
Why?
| | Text Messaging | 3 | 2016 | 188 | 0.290 |
Why?
| | Safety-net Providers | 2 | 2021 | 133 | 0.280 |
Why?
| | Papillomavirus Infections | 3 | 2024 | 345 | 0.260 |
Why?
| | Health Surveys | 3 | 2025 | 511 | 0.240 |
Why?
| | Weight Loss | 3 | 2017 | 858 | 0.230 |
Why?
| | Growth Charts | 1 | 2025 | 20 | 0.230 |
Why?
| | Adolescent | 20 | 2025 | 22557 | 0.230 |
Why?
| | Anxiety | 2 | 2025 | 1125 | 0.230 |
Why?
| | Rural Health Services | 2 | 2024 | 139 | 0.220 |
Why?
| | Hypertension | 3 | 2022 | 1272 | 0.210 |
Why?
| | Sex Chromosome Disorders | 1 | 2025 | 27 | 0.210 |
Why?
| | Female | 38 | 2025 | 79499 | 0.210 |
Why?
| | Weight Reduction Programs | 2 | 2017 | 140 | 0.210 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2024 | 14 | 0.210 |
Why?
| | Body Height | 1 | 2025 | 205 | 0.210 |
Why?
| | Child | 18 | 2025 | 22693 | 0.210 |
Why?
| | Trisomy | 1 | 2025 | 79 | 0.200 |
Why?
| | Neurofilament Proteins | 1 | 2024 | 83 | 0.200 |
Why?
| | Obesity | 5 | 2023 | 3131 | 0.200 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2024 | 124 | 0.200 |
Why?
| | Healthcare Disparities | 3 | 2024 | 733 | 0.200 |
Why?
| | Rural Population | 3 | 2024 | 677 | 0.200 |
Why?
| | Urban Population | 2 | 2024 | 497 | 0.190 |
Why?
| | Colorado | 9 | 2025 | 4595 | 0.190 |
Why?
| | Food Assistance | 1 | 2023 | 34 | 0.190 |
Why?
| | Internal Medicine | 1 | 2025 | 280 | 0.180 |
Why?
| | Postpartum Period | 2 | 2023 | 377 | 0.180 |
Why?
| | Male | 30 | 2025 | 73396 | 0.180 |
Why?
| | Ambulatory Care | 2 | 2025 | 628 | 0.180 |
Why?
| | Humans | 45 | 2025 | 146342 | 0.180 |
Why?
| | Genetic Linkage | 2 | 2022 | 271 | 0.180 |
Why?
| | Physicians, Primary Care | 1 | 2024 | 210 | 0.170 |
Why?
| | Cardiovascular Diseases | 3 | 2025 | 2219 | 0.170 |
Why?
| | Dental Caries | 1 | 2023 | 173 | 0.170 |
Why?
| | Gender Dysphoria | 1 | 2021 | 19 | 0.170 |
Why?
| | Disorders of Sex Development | 1 | 2021 | 40 | 0.170 |
Why?
| | Electronic Health Records | 3 | 2025 | 1210 | 0.160 |
Why?
| | Mood Disorders | 1 | 2021 | 130 | 0.160 |
Why?
| | Dyslipidemias | 1 | 2022 | 184 | 0.150 |
Why?
| | Child, Preschool | 9 | 2025 | 11913 | 0.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2024 | 1408 | 0.150 |
Why?
| | Liver Diseases | 1 | 2022 | 304 | 0.140 |
Why?
| | Infant | 9 | 2025 | 10114 | 0.140 |
Why?
| | Chromosomes, Human, Pair 16 | 1 | 2019 | 36 | 0.140 |
Why?
| | Practice Patterns, Physicians' | 2 | 2024 | 1408 | 0.140 |
Why?
| | Case-Control Studies | 5 | 2025 | 3647 | 0.140 |
Why?
| | Logistic Models | 5 | 2021 | 2126 | 0.140 |
Why?
| | Feasibility Studies | 1 | 2023 | 1135 | 0.140 |
Why?
| | United States | 12 | 2025 | 16136 | 0.140 |
Why?
| | Communication | 1 | 2025 | 980 | 0.140 |
Why?
| | Information Seeking Behavior | 1 | 2018 | 39 | 0.130 |
Why?
| | Adult | 17 | 2025 | 41087 | 0.130 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 102 | 0.130 |
Why?
| | Osteoprotegerin | 1 | 2017 | 24 | 0.130 |
Why?
| | Exome | 1 | 2019 | 233 | 0.130 |
Why?
| | Cardiologists | 1 | 2017 | 45 | 0.130 |
Why?
| | Precision Medicine | 1 | 2022 | 462 | 0.130 |
Why?
| | Organizations, Nonprofit | 1 | 2017 | 17 | 0.130 |
Why?
| | Birth Order | 1 | 2017 | 15 | 0.130 |
Why?
| | Lost to Follow-Up | 1 | 2017 | 19 | 0.130 |
Why?
| | Genome-Wide Association Study | 2 | 2022 | 1537 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 389 | 0.130 |
Why?
| | Infant, Newborn | 7 | 2025 | 6460 | 0.120 |
Why?
| | Population Density | 1 | 2017 | 91 | 0.120 |
Why?
| | Hearing Tests | 1 | 2017 | 41 | 0.120 |
Why?
| | Parenting | 1 | 2020 | 309 | 0.120 |
Why?
| | Qualitative Research | 1 | 2024 | 1734 | 0.120 |
Why?
| | Genome, Human | 1 | 2019 | 431 | 0.120 |
Why?
| | Health Promotion | 3 | 2023 | 786 | 0.120 |
Why?
| | Time-to-Treatment | 1 | 2018 | 257 | 0.120 |
Why?
| | Blood Pressure | 2 | 2022 | 1765 | 0.120 |
Why?
| | Attitude of Health Personnel | 1 | 2024 | 1219 | 0.110 |
Why?
| | Patient Readmission | 1 | 2021 | 778 | 0.110 |
Why?
| | Cross-Sectional Studies | 6 | 2025 | 5899 | 0.110 |
Why?
| | Renal Dialysis | 3 | 2009 | 461 | 0.110 |
Why?
| | Young Adult | 9 | 2025 | 14330 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2019 | 539 | 0.110 |
Why?
| | Aftercare | 1 | 2017 | 225 | 0.110 |
Why?
| | Middle Aged | 15 | 2025 | 36619 | 0.110 |
Why?
| | Neonatal Screening | 1 | 2017 | 185 | 0.110 |
Why?
| | Influenza, Human | 1 | 2021 | 640 | 0.110 |
Why?
| | Depression | 1 | 2025 | 1575 | 0.110 |
Why?
| | Adolescent Health Services | 1 | 2015 | 74 | 0.110 |
Why?
| | Prevalence | 4 | 2025 | 2861 | 0.110 |
Why?
| | Down Syndrome | 1 | 2021 | 529 | 0.110 |
Why?
| | Odds Ratio | 3 | 2021 | 1077 | 0.110 |
Why?
| | Exercise Test | 1 | 2017 | 637 | 0.100 |
Why?
| | Hearing Loss | 1 | 2017 | 177 | 0.100 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 365 | 0.100 |
Why?
| | Genetic Variation | 1 | 2019 | 996 | 0.100 |
Why?
| | Needs Assessment | 1 | 2016 | 404 | 0.090 |
Why?
| | Biomarkers | 1 | 2024 | 4340 | 0.090 |
Why?
| | Prediabetic State | 1 | 2016 | 250 | 0.090 |
Why?
| | Age of Onset | 2 | 2025 | 558 | 0.090 |
Why?
| | Myocardium | 1 | 2017 | 948 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2363 | 0.090 |
Why?
| | Risk Assessment | 1 | 2021 | 3712 | 0.090 |
Why?
| | Gonadotropin-Releasing Hormone | 2 | 2024 | 215 | 0.090 |
Why?
| | Kidney Failure, Chronic | 2 | 2009 | 589 | 0.090 |
Why?
| | Patient Compliance | 1 | 2016 | 589 | 0.090 |
Why?
| | Poverty | 3 | 2023 | 530 | 0.080 |
Why?
| | Appointments and Schedules | 2 | 2025 | 97 | 0.080 |
Why?
| | Urban Health Services | 2 | 2021 | 68 | 0.080 |
Why?
| | Cohort Studies | 4 | 2025 | 6077 | 0.080 |
Why?
| | Aged | 9 | 2025 | 26432 | 0.070 |
Why?
| | Estradiol | 2 | 2023 | 517 | 0.070 |
Why?
| | Propensity Score | 2 | 2021 | 376 | 0.070 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 6073 | 0.070 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2009 | 21 | 0.070 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 94 | 0.070 |
Why?
| | Retrospective Studies | 7 | 2021 | 17438 | 0.060 |
Why?
| | Risk Factors | 5 | 2021 | 10921 | 0.060 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 102 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2418 | 0.060 |
Why?
| | Minority Groups | 2 | 2018 | 286 | 0.060 |
Why?
| | XYY Karyotype | 1 | 2025 | 24 | 0.050 |
Why?
| | Sex Chromosome Disorders of Sex Development | 1 | 2025 | 16 | 0.050 |
Why?
| | Body Mass Index | 3 | 2025 | 2458 | 0.050 |
Why?
| | Time Factors | 4 | 2018 | 7109 | 0.050 |
Why?
| | Washington | 1 | 2025 | 157 | 0.050 |
Why?
| | Guatemala | 2 | 2016 | 349 | 0.050 |
Why?
| | Chromosomes, Human, X | 1 | 2025 | 76 | 0.050 |
Why?
| | Hospitals | 2 | 2021 | 738 | 0.050 |
Why?
| | Sex Chromosome Aberrations | 1 | 2025 | 67 | 0.050 |
Why?
| | Muscular Atrophy | 1 | 2005 | 88 | 0.050 |
Why?
| | Psychotropic Drugs | 1 | 2025 | 75 | 0.050 |
Why?
| | Reference Values | 1 | 2025 | 796 | 0.050 |
Why?
| | Heart Failure | 1 | 2017 | 2329 | 0.050 |
Why?
| | Smoking | 2 | 2024 | 1486 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2019 | 5439 | 0.050 |
Why?
| | Sleep Wake Disorders | 1 | 2007 | 314 | 0.050 |
Why?
| | Dental Hygienists | 1 | 2023 | 14 | 0.050 |
Why?
| | Neuroglia | 1 | 2024 | 177 | 0.050 |
Why?
| | Motivational Interviewing | 1 | 2025 | 121 | 0.050 |
Why?
| | Patient Acceptance of Health Care | 2 | 2022 | 881 | 0.050 |
Why?
| | Job Satisfaction | 1 | 2025 | 236 | 0.050 |
Why?
| | Isometric Contraction | 1 | 2005 | 200 | 0.050 |
Why?
| | Testosterone Congeners | 1 | 2022 | 7 | 0.050 |
Why?
| | Cigarette Smoking | 1 | 2024 | 103 | 0.050 |
Why?
| | Vaccination Coverage | 1 | 2024 | 106 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8391 | 0.040 |
Why?
| | Body Weight | 1 | 2025 | 968 | 0.040 |
Why?
| | Patient Satisfaction | 1 | 2025 | 706 | 0.040 |
Why?
| | Linear Models | 2 | 2017 | 857 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2022 | 183 | 0.040 |
Why?
| | Lower Extremity | 1 | 2005 | 453 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2024 | 930 | 0.040 |
Why?
| | Child Behavior Disorders | 1 | 2021 | 117 | 0.040 |
Why?
| | Motor Activity | 1 | 2005 | 704 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 278 | 0.040 |
Why?
| | Autism Spectrum Disorder | 1 | 2025 | 406 | 0.040 |
Why?
| | Comorbidity | 1 | 2025 | 1665 | 0.040 |
Why?
| | Influenza Vaccines | 1 | 2024 | 544 | 0.040 |
Why?
| | Recombinases | 1 | 2019 | 10 | 0.040 |
Why?
| | Mental Health | 1 | 2025 | 779 | 0.030 |
Why?
| | Suicidal Ideation | 1 | 2024 | 543 | 0.030 |
Why?
| | Burnout, Professional | 1 | 2025 | 493 | 0.030 |
Why?
| | Attitude | 1 | 2020 | 253 | 0.030 |
Why?
| | Testosterone | 1 | 2022 | 419 | 0.030 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 66 | 0.030 |
Why?
| | Developmental Disabilities | 1 | 2021 | 281 | 0.030 |
Why?
| | Mentors | 1 | 2020 | 217 | 0.030 |
Why?
| | Quality of Life | 2 | 2007 | 3200 | 0.030 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 222 | 0.030 |
Why?
| | Mississippi | 1 | 2017 | 34 | 0.030 |
Why?
| | Nuclear Family | 1 | 2018 | 51 | 0.030 |
Why?
| | Health Personnel | 1 | 2024 | 754 | 0.030 |
Why?
| | Hospitalization | 2 | 2024 | 2475 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1888 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 429 | 0.030 |
Why?
| | Health Behavior | 1 | 2023 | 802 | 0.030 |
Why?
| | Patient Care Team | 1 | 2023 | 701 | 0.030 |
Why?
| | Pediatricians | 1 | 2018 | 120 | 0.030 |
Why?
| | Mastectomy | 1 | 2018 | 189 | 0.030 |
Why?
| | Altitude | 1 | 2021 | 469 | 0.030 |
Why?
| | Alcoholism | 1 | 2024 | 830 | 0.030 |
Why?
| | Suicide | 1 | 2024 | 647 | 0.030 |
Why?
| | Pregnancy | 2 | 2021 | 7230 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2024 | 850 | 0.030 |
Why?
| | Maternal Age | 1 | 2017 | 129 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2020 | 3017 | 0.030 |
Why?
| | Insurance Coverage | 1 | 2018 | 248 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 382 | 0.030 |
Why?
| | Alternative Splicing | 1 | 2019 | 253 | 0.030 |
Why?
| | Quality Improvement | 1 | 2025 | 1354 | 0.030 |
Why?
| | Emigration and Immigration | 1 | 2017 | 67 | 0.030 |
Why?
| | Obstetrics | 1 | 2018 | 179 | 0.030 |
Why?
| | Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2016 | 28 | 0.030 |
Why?
| | Haemophilus Vaccines | 1 | 2016 | 29 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2017 | 219 | 0.030 |
Why?
| | Peru | 1 | 2016 | 61 | 0.030 |
Why?
| | Income | 1 | 2017 | 206 | 0.030 |
Why?
| | Rotavirus Vaccines | 1 | 2016 | 39 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 376 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2024 | 1107 | 0.030 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2016 | 49 | 0.030 |
Why?
| | Hepatitis B Vaccines | 1 | 2016 | 43 | 0.030 |
Why?
| | Algorithms | 1 | 2023 | 1849 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 78 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1493 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3206 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1668 | 0.030 |
Why?
| | Cell Phone | 1 | 2016 | 83 | 0.030 |
Why?
| | Pandemics | 1 | 2024 | 1707 | 0.030 |
Why?
| | Women's Health | 1 | 2017 | 317 | 0.030 |
Why?
| | Educational Status | 1 | 2017 | 466 | 0.030 |
Why?
| | Prognosis | 3 | 2009 | 4351 | 0.030 |
Why?
| | Immunization Schedule | 1 | 2016 | 187 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1818 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1488 | 0.030 |
Why?
| | Echocardiography | 1 | 2017 | 645 | 0.030 |
Why?
| | Stroke Volume | 1 | 2017 | 652 | 0.030 |
Why?
| | Insurance, Health | 1 | 2017 | 318 | 0.030 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 541 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2022 | 2240 | 0.030 |
Why?
| | Immunization Programs | 1 | 2016 | 194 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1327 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1543 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1996 | 0.030 |
Why?
| | Primary Health Care | 1 | 2024 | 1776 | 0.020 |
Why?
| | Sexual Behavior | 1 | 2018 | 490 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2488 | 0.020 |
Why?
| | Medicaid | 1 | 2017 | 477 | 0.020 |
Why?
| | Vascular Stiffness | 1 | 2017 | 488 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2017 | 594 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2017 | 762 | 0.020 |
Why?
| | Sex Factors | 1 | 2017 | 2107 | 0.020 |
Why?
| | Program Evaluation | 1 | 2016 | 952 | 0.020 |
Why?
| | Caregivers | 1 | 2020 | 1080 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1998 | 0.020 |
Why?
| | Exercise | 1 | 2023 | 2213 | 0.020 |
Why?
| | Decision Making | 1 | 2018 | 993 | 0.020 |
Why?
| | Mothers | 1 | 2016 | 772 | 0.020 |
Why?
| | Cognition | 1 | 2018 | 1292 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1591 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2009 | 329 | 0.020 |
Why?
| | Japan | 1 | 2007 | 149 | 0.020 |
Why?
| | Europe | 1 | 2007 | 421 | 0.020 |
Why?
| | Electric Impedance | 1 | 2005 | 108 | 0.010 |
Why?
| | Survival Rate | 1 | 2009 | 2092 | 0.010 |
Why?
| | Kidney Diseases | 1 | 2007 | 428 | 0.010 |
Why?
| | Survival Analysis | 1 | 2006 | 1378 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 2113 | 0.010 |
Why?
| | Gait | 1 | 2005 | 322 | 0.010 |
Why?
| | Body Composition | 1 | 2005 | 689 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 11821 | 0.010 |
Why?
| | Adipose Tissue | 1 | 2005 | 642 | 0.010 |
Why?
| | Walking | 1 | 2005 | 546 | 0.010 |
Why?
|
|
Furniss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|